Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sirohi

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
ESMO Open|November 7, 2024
What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists' perceptions on endpoints, benefit, price, and value of cancer drugsS S Datta, V Sharma, A Mukherjee, et al.
Indian Journal of Cancer|February 25, 2016
Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer centerB Sirohi, S Dawood, S Rastogi, et al.
British Journal of Cancer|April 5, 2007
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tractV Formica, A Wotherspoon, D Cunningham, et al.
Bone Marrow Transplantation|June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?J Mehta, R Powles, B Sirohi, et al.
Indian Journal of Cancer|August 9, 2014
Ignore molecular oncology at your perilP M Parikh, K Prabhash, G S Bhattacharyya, et al.
Bone Marrow Transplantation|July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?J Mehta, R Powles, B Sirohi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2008
Platinum-based chemotherapy in triple-negative breast cancerB Sirohi, M Arnedos, S Popat, et al.
Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2008
Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphomaB Sirohi, D Cunningham, R Powles, et al.
Annals of Hematology|August 10, 2006
Consensus conference on European preparedness for haematological and other medical management of mass radiation accidentsN-C Gorin, T M Fliedner, P Gourmelon, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
ESMO Open|November 7, 2024
What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists' perceptions on endpoints, benefit, price, and value of cancer drugsS S Datta, V Sharma, A Mukherjee, et al.
Indian Journal of Cancer|February 25, 2016
Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer centerB Sirohi, S Dawood, S Rastogi, et al.
British Journal of Cancer|April 5, 2007
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tractV Formica, A Wotherspoon, D Cunningham, et al.
Bone Marrow Transplantation|June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?J Mehta, R Powles, B Sirohi, et al.
Indian Journal of Cancer|August 9, 2014
Ignore molecular oncology at your perilP M Parikh, K Prabhash, G S Bhattacharyya, et al.
Bone Marrow Transplantation|July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?J Mehta, R Powles, B Sirohi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2008
Platinum-based chemotherapy in triple-negative breast cancerB Sirohi, M Arnedos, S Popat, et al.
Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2008
Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphomaB Sirohi, D Cunningham, R Powles, et al.
Annals of Hematology|August 10, 2006
Consensus conference on European preparedness for haematological and other medical management of mass radiation accidentsN-C Gorin, T M Fliedner, P Gourmelon, et al.
Pageof 5